Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical devices. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.
Cachet Pharmaceutical Co Ltd (002462) - Total Assets
Latest total assets as of September 2025: CN¥12.68 Billion CNY
Based on the latest financial reports, Cachet Pharmaceutical Co Ltd (002462) holds total assets worth CN¥12.68 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cachet Pharmaceutical Co Ltd - Total Assets Trend (2007–2024)
This chart illustrates how Cachet Pharmaceutical Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cachet Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Cachet Pharmaceutical Co Ltd's total assets of CN¥12.68 Billion consist of 92.6% current assets and 7.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.8% |
| Accounts Receivable | CN¥7.25 Billion | 51.7% |
| Inventory | CN¥2.74 Billion | 19.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥24.45 Million | 0.2% |
| Goodwill | CN¥395.45 Million | 2.8% |
Asset Composition Trend (2007–2024)
This chart illustrates how Cachet Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cachet Pharmaceutical Co Ltd's current assets represent 92.6% of total assets in 2024, an increase from 48.1% in 2007.
- Cash Position: Cash and equivalents constituted 15.8% of total assets in 2024, up from 11.3% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 6.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 51.7% of total assets.
Cachet Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Cachet Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
|
Arich Enterprise Co Ltd
TWO:4173
|
Taiwan | NT$5.63 Billion |
Cachet Pharmaceutical Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cachet Pharmaceutical Co Ltd generates 1.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Cachet Pharmaceutical Co Ltd generates $ 1.14 in net profit.
Cachet Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.81 | 1.64 | 1.46 |
| Quick Ratio | 1.40 | 1.32 | 1.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥5.24 Billion | CN¥ 5.25 Billion | CN¥ 3.97 Billion |
Cachet Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Cachet Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.02 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -18.0% |
| Total Assets | CN¥14.04 Billion |
| Market Capitalization | $439.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cachet Pharmaceutical Co Ltd's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cachet Pharmaceutical Co Ltd's assets decreased by 18.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cachet Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual total assets of Cachet Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥14.04 Billion | -18.01% |
| 2023-12-31 | CN¥17.12 Billion | +3.41% |
| 2022-12-31 | CN¥16.56 Billion | +10.84% |
| 2021-12-31 | CN¥14.94 Billion | +5.69% |
| 2020-12-31 | CN¥14.13 Billion | +8.41% |
| 2019-12-31 | CN¥13.04 Billion | +20.16% |
| 2018-12-31 | CN¥10.85 Billion | +17.88% |
| 2017-12-31 | CN¥9.20 Billion | +24.73% |
| 2016-12-31 | CN¥7.38 Billion | +25.36% |
| 2015-12-31 | CN¥5.89 Billion | +29.46% |
| 2014-12-31 | CN¥4.55 Billion | +63.08% |
| 2013-12-31 | CN¥2.79 Billion | +45.24% |
| 2012-12-31 | CN¥1.92 Billion | +21.60% |
| 2011-12-31 | CN¥1.58 Billion | +10.62% |
| 2010-12-31 | CN¥1.43 Billion | +55.59% |
| 2009-12-31 | CN¥917.28 Million | +24.94% |
| 2008-12-31 | CN¥734.16 Million | -14.49% |
| 2007-12-31 | CN¥858.54 Million | -- |